🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jennifer J. Knox

Ontario Institute for Cancer Research

ORCID: 0000-0003-3474-6647

Also affiliated with University Health Network, Princess Margaret Cancer Centre, Occupational Cancer Research Centre

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “O-2 Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)”.

O-2 Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)

Annals of Oncology(2023)10.1016/j.annonc.2023.04.017
N/A
0.624DataRank · unranked
5 citations

I. Bazin, Do‐Youn Oh, O. Zubkov, V. Breder, Li‐Yuan Bai +16 more

Defining incidence and complications of fibrolamellar liver cancer through tiered computational analysis of clinical data

npj Precision Oncology(2023)10.1038/s41698-023-00371-2
N/A
0.453DataRank · unranked
16 citations

Kurt P. Losert, Samantha M. Maisel, Jennifer Wild, Amin Yaqubie, Michael Herman +9 more

CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

Cancer Research Communications(2024)10.1158/2767-9764.crc-22-0516
N/A
0.216DataRank · unranked
2 citations

Susan M. Geyer, Andrew B. Nixon, Federico Innocenti, Qian Shi, Priya Kumthekar +16 more

Defining incidence and complications of fibrolamellar liver cancer through tiered computational analysis of multiple clinical data types.

Research Square(2022)10.21203/rs.3.rs-2082118/v1
N/A
0DataRank · unranked
0 citations

Travis Zack, Jennifer Wild, Samantha Maisel, Amin Yaqubie, Jennifer J. Knox +7 more

NRG/RTOG 1112: Randomized phase III study of sorafenib vs. stereotactic body radiation therapy (SBRT) followed by sorafenib in hepatocellular carcinoma (HCC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.489
N/A
0DataRank · unranked
60 citations

Kathryn Winter, Jennifer J. Knox, Andrew X. Zhu, Sunil Krishnan, Chandan Guha +15 more